• About us
  • Membership
  • Contact us
  • Tue August 19, 2025

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

spinal muscular atrophy

Total:2

  • Oral medicine for SMA patients delivered to Iran 2022-08-09 18:47

    Oral medicine for SMA patients delivered to Iran

    TEHRAN – The first shipment of Evrysdi, an oral medication used to treat spinal muscular atrophy (SMA), has been imported to the country, Saeed Azamian, CEO of the SMA Association of Iran, said on Tuesday.

  • FDA imports medicine for SMA patients 2022-08-02 18:57

    FDA imports medicine for SMA patients

    TEHRAN – The first batch of SPINRAZA – a drug special for patients suffering from spinal muscular atrophy (SMA) - has arrived in the country, the Food and Drug Administration director announced on Tuesday.

All Pages

Latest

  • Iran, Jordan judo federations sign MoU

  • High potential for creating global collection of Malayer carpets

  • Cultural heritage bell to be rung in schools

  • Azerbaijan Airlines to resume Tehran flights, launch new Tabriz route in September

  • Archaeological survey launched to protect Surt in northern Iran

  • Trans-Iranian Railway among top 5 registered by UNESCO

  • Shiraz emerges as key health tourism hub

  • Knowledge-based companies to attend Arablab    

  • Iran, Armenia sign cooperation documents in different areas

  • National youth population award slated for November

  • Education, AI crucial to address non-communicable diseases: health minister

  • ‘World Humanitarian Day, an opportunity to showcase solidarity among nations’

  • Sponge iron export up 30% in 4 months on year

  • Solar power plants opened in Qazvin with 6 MW capacity

  • Economy minister outlines new financing plans to curb inflation, support production

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio